Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TCM Prescriptions in Unstable Angina
NCT03171597Phase 4Unknown
- Start
- Aug 2017
- Primary completion
- Oct 2019
- Modality
- Small Molecules
01
Overview
Phase 4, open-label trial of shuanghe decoction, xuefu zhuyu, gualou xiebai banxia decoction and salvia miltiorrhiza in unstable angina (4 arms). Primary endpoint: Mortality at 6 months. Status: unknown.
02
Drugs
shuanghe decoctionxuefu zhuyugualou xiebai banxia decoctionsalvia miltiorrhiza
03
Conditions
unstable angina
Beyond the preview
Go deeper on NCT03171597.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03171597.